Latest News about BIIB
Recent news which mentions BIIB
Wall Street predicts approval for another ALS drug
March 21, 2023
From MarketWatch
Despite Failed Phase 3 Study, FDA Staff Says Biogen's ALS Drug May Have Clinical Benefit
March 21, 2023
Tickers
BIIB
From Benzinga
From Benzinga
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
March 16, 2023
From Benzinga
Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
March 16, 2023
From Benzinga
Analyst Says Biogen-Eisai's Alzheimer's Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity
March 14, 2023
From Benzinga
Analyst Creates Bullish Pitch For Sage Therapeutics Around Greater Enthusiasm For Its Depression Drug, Zuranolone
March 13, 2023
From Benzinga
Insider Richard Barry Is Betting Big on Cassava (SAVA) Stock
March 09, 2023
From InvestorPlace
Why Shares of Anavex Life Sciences Rose 12.4% in February
March 06, 2023
From Motley Fool
From Benzinga
From MarketWatch
FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
February 28, 2023
From MarketWatch
Why Reata Pharmaceuticals Shares Are Falling Monday?
February 27, 2023
From Benzinga
From Benzinga
Cisco, Analog Devices And 3 Stocks To Watch Heading Into Wednesday
February 15, 2023
From Benzinga
US Stocks Settle Mixed; Investor Optimism Improves
February 15, 2023
From Benzinga
Q4 Reporting Season Pushes Past Halfway Mark: Coca-Cola, Cisco Systems, Palantir, Roku Lead Earnings This Week
February 12, 2023
From Benzinga
2 Top Biotech Stocks Defying the Bear Market
February 08, 2023
From Motley Fool
Why Anavex Life Sciences Stock Bolted Higher in January
February 08, 2023
From Motley Fool
Can the government’s new ability to negotiate drug prices eliminate blockbuster price tags?
February 08, 2023
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.